Company intelligence / Profile preview
Cystetic Medicines
Champaign, Illinois, United Statescysteticmedicines.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has demonstrated proof-of-concept in preclinical and early clinical studies showing that their molecular prosthetic approach can restore anion transport in people with cystic fibrosis not on modulators. Their lead program, CM001, has completed dosing of healthy volunteers and initiated dosing in people with CF as part of an ongoing Phase 1 trial. Early biomarker data are promising.
- Therapeutic areas
- Rare Diseases
- Modalities
- Small molecules (specifically, small molecule ion channel prosthetics)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
DevPro BioPharma (supporting clinical development)
Beyond the preview
Go deeper on Cystetic Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cystetic Medicines.